Advertisement

Neuropathological Techniques to Investigate CNS Pathology in Experimental Autoimmune Encephalomyelitis (EAE)

  • Karin Steinbach
  • Doron MerklerEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1304)

Abstract

Neuropathological techniques such as conventional and immunohistochemical staining of paraffin-embedded tissue sections are instrumental for identification and characterization of aberrations of organ architecture during human inflammatory disorders of the central nervous system (CNS) as in their animal models. Here we describe step-by-step protocols for tissue processing, sectioning, and conventional and immunohistochemical stainings to display as well as quantify CNS inflammation, demyelination, and neuronal damage in experimental autoimmune encephalomyelitis (EAE), an animal model of Multiple Sclerosis (MS).

Keywords

Experimental autoimmune encephalomyelitis EAE Multiple sclerosis MS Histology Pathology Neuropathology Central nervous system CNS Myelin Axon Hematoxylin Luxol fast blue Bielschowsky HE LFB PAS Inflammation Autoimmunity 

Notes

Acknowledgments

D.M. is supported by the Swiss National Science Foundation (No. PP00P3_128372 and PP00P3_152928), Swiss MS Society, Klaus Tschira Foundation, and Gebert Rüf Foundation.

References

  1. 1.
    Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517. doi: 10.1016/S0140-6736(08)61620-7 PubMedCrossRefGoogle Scholar
  2. 2.
    Charcot J (1880) Lecons sur les maladies du systeme nerveux faites a la Salpetriere, vol 1, 4th edn. Bureau du Progrès Médical: V.A Delahaye et Co., ParisGoogle Scholar
  3. 3.
    Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338(5):278–285. doi: 10.1056/NEJM199801293380502 PubMedCrossRefGoogle Scholar
  4. 4.
    Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt 3):393–399PubMedCrossRefGoogle Scholar
  5. 5.
    Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707–717PubMedCrossRefGoogle Scholar
  6. 6.
    Lassmann H, Wekerle H (2005) The pathology of multiple sclerosis. In: Compston A, McDonald I, Noseworthy JH et al. (eds) McAlpine's Multiple Sclerosis. 4 edn. Churchill Livingstone, London, pp 557–599Google Scholar
  7. 7.
    Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123(Pt 6):1174–1183PubMedCrossRefGoogle Scholar
  8. 8.
    Mayer P (1896) Ueber Schleimfarbung. Mitt zool Stn Neapel 12:303Google Scholar
  9. 9.
    Lillie R (1965) Histopathologic technic and practical histochemistry, 3rd edn. McGraw-Hill Book Co., New York, NYGoogle Scholar
  10. 10.
    Kluver H, Barrera E (1953) A method for the combined staining of cells and fibers in the nervous system. J Neuropathol Exp Neurol 12(4):400–403PubMedCrossRefGoogle Scholar
  11. 11.
    Bielschowsky M (1903) Zur Histologie der Multiplen Sklerose. Neurol Centralblatt 22:770–777Google Scholar
  12. 12.
    Bielschowsky M (1904) Die marklosen nervenfasern in den herden der multiplen sklerose: eine antwort an herrn strähuber. Neurol Centralblatt 16:59–62Google Scholar
  13. 13.
    Schattling B, Steinbach K, Thies E, Kruse M, Menigoz A, Ufer F, Flockerzi V, Bruck W, Pongs O, Vennekens R, Kneussel M, Freichel M, Merkler D, Friese MA (2012) TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 18(12):1805–1811. doi: 10.1038/nm.3015 PubMedCrossRefGoogle Scholar
  14. 14.
    Nikic I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, Bruck W, Bishop D, Misgeld T, Kerschensteiner M (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17(4):495–499. doi: 10.1038/nm.2324 PubMedCrossRefGoogle Scholar
  15. 15.
    Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129(Pt 8):1953–1971. doi: 10.1093/brain/awl075 PubMedCrossRefGoogle Scholar
  16. 16.
    Herrero-Herranz E, Pardo LA, Gold R, Linker RA (2008) Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 30(2):162–173. doi: 10.1016/j.nbd.2008.01.001 PubMedCrossRefGoogle Scholar
  17. 17.
    Mendel I, Kerlero de Rosbo N, Ben-Nun A (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 25(7):1951–1959. doi: 10.1002/eji.1830250723 PubMedCrossRefGoogle Scholar
  18. 18.
    Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, Olsson T, Linington C, Lassmann H (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8(4):681–694PubMedCrossRefGoogle Scholar
  19. 19.
    Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157(1):267–276. doi: 10.1016/S0002-9440(10)64537-3 PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW (1993) Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett 160(2):139–144PubMedCrossRefGoogle Scholar
  21. 21.
    Sherriff FE, Bridges LR, Sivaloganathan S (1994) Early detection of axonal injury after human head trauma using immunocytochemistry for beta-amyloid precursor protein. Acta Neuropathol 87(1):55–62PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Pathology and ImmunologyUniversity of GenevaGenevaSwitzerland
  2. 2.Department of NeuropathologyUniversity Medical Center GöttingenGöttingenGermany

Personalised recommendations